SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation

Molecular and Cellular Biology

Volumn 22, Issue 13, 2002, Pages 4567-4578

  Krebs, Danielle L ^a   Uren, Rachel T ^a   Metcalf, Donald ^a   Rakar, Steven ^a   Zhang, Jian Guo ^a   Starr, Robyn ^a   De Souza, David P ^a   Hanzinikolas, Kathy ^a   Eyles, Jo ^a   Connolly, Lisa M ^a   Simpson, Richard J ^a   Nicola, Nicos A ^a   Nicholson, Sandra E ^a   Baca, Manuel ^a   Hilton, Douglas J ^a   Alexander, Warren S ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 2; INSULIN RECEPTOR SUBSTRATE 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN; PROTEIN SOCS 6; SUPPRESSOR OF CYTOKINE SIGNALING; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GROWTH RETARDATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BINDING SITES; BLOOD GLUCOSE; BODY CONSTITUTION; FEMALE; GROWTH; HEMATOPOIETIC SYSTEM; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PHOSPHOPROTEINS; PROTEINS; SRC HOMOLOGY DOMAINS; TRANSCRIPTION FACTORS;

ANIMALIA; MURINAE;

EID: 0036275657     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.13.4567-4578.2002     Document Type: Article

References (44)

1. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity
2. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine
3. Role of brain insulin receptor in control of body weight and reproduction
4. IRS proteins and beta-cell function
5. Insulin resistance: Cellular and clinical concepts
6. The lipid phosphatase SHIP2 controls insulin sensitivity
7. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation
8. Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation
9. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
10. Characterization of hematopoietic progenitor cells that express the transcription factor SCL, using a lacZ "knock-in" strategy
11. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation
12. Insulin receptor substrate (IRS) transduction system: Distinct and overlapping signaling potential
13. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box
14. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins
15. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling
16. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2
17. MUF1, a novel elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase
18. The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families
19. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation
20. Functional analysis of Asb-1 using genetic modification in mice
21. Simple screening procedure to detect gene targeting events in embryonic stem cells
22. SOCS: Physiological suppressors of cytokine signaling
23. SOCS3 is essential in the regulation of fetal liver erythropoiesis
24. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality
25. Cloning and characterization of novel CIS family genes
26. A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs
27. Gigantism in mice lacking suppressor of cytokine signalling-2
28. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells
29. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance
30. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice
31. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction
32. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling
33. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone
34. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms
35. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3
36. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain
37. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1
38. A family of cytokine-inducible inhibitors of signalling
39. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
40. Signals that regulate food intake and energy homeostasis
41. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
42. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
43. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation
44. Mechanism of STAT3 activation by insulin-like growth factor I receptor